Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study.
Yokota T, Ogawa T, Takahashi S, Okami K, Fujii T, Tanaka K, Iwae S, Ota I, Ueda T, Monden N, Matsuura K, Kojima H, Ueda S, Sasaki K, Fujimoto Y, Hasegawa Y, Beppu T, Nishimori H, Hirano S, Naka Y, Matsushima Y, Fujii M, Tahara M. Yokota T, et al. Among authors: monden n. BMC Cancer. 2017 May 5;17(1):314. doi: 10.1186/s12885-017-3295-4. BMC Cancer. 2017. PMID: 28476132 Free PMC article. Clinical Trial.
Salvage surgery for recurrent oropharyngeal cancer after chemoradiotherapy.
Kano S, Homma A, Hayashi R, Kawabata K, Yoshino K, Iwae S, Hasegawa Y, Nibu K, Kato T, Shiga K, Matsuura K, Monden N, Fujii M. Kano S, et al. Among authors: monden n. Int J Clin Oncol. 2013 Oct;18(5):817-23. doi: 10.1007/s10147-012-0449-x. Epub 2012 Jul 25. Int J Clin Oncol. 2013. PMID: 22829207
Platinum-based chemotherapy plus cetuximab for the first-line treatment of Japanese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: results of a phase II trial.
Yoshino T, Hasegawa Y, Takahashi S, Monden N, Homma A, Okami K, Onozawa Y, Fujii M, Taguchi T, de Blas B, Beier F, Tahara M. Yoshino T, et al. Among authors: monden n. Jpn J Clin Oncol. 2013 May;43(5):524-31. doi: 10.1093/jjco/hyt034. Epub 2013 Mar 10. Jpn J Clin Oncol. 2013. PMID: 23479384 Free PMC article. Clinical Trial.
Lymph node metastasis in t4 maxillary sinus squamous cell carcinoma: incidence and treatment outcome.
Homma A, Hayashi R, Matsuura K, Kato K, Kawabata K, Monden N, Hasegawa Y, Onitsuka T, Fujimoto Y, Iwae S, Okami K, Matsuzuka T, Yoshino K, Nibu K, Kato T, Nishino H, Asakage T, Ota I, Kitamura M, Kubota A, Ueda T, Ikebuchi K, Watanabe A, Fujii M. Homma A, et al. Among authors: monden n. Ann Surg Oncol. 2014 May;21(5):1706-10. doi: 10.1245/s10434-014-3544-6. Epub 2014 Feb 20. Ann Surg Oncol. 2014. PMID: 24554063 Free article.
Japanese Board Certification System for head and neck surgeons.
Yoshimoto S, Nakashima T, Fujii T, Matsuura K, Otsuki N, Asakage T, Fujimoto Y, Hanai N, Homma A, Monden N, Okami K, Sugasawa M, Hasegawa Y, Nibu K, Kamata SE, Kishimoto S, Kohno N, Fukuda S, Hisa Y. Yoshimoto S, et al. Among authors: monden n. Auris Nasus Larynx. 2014 Aug;41(4):327-30. doi: 10.1016/j.anl.2013.10.019. Epub 2014 Feb 26. Auris Nasus Larynx. 2014. PMID: 24581685
Multi-institutional retrospective study for the evaluation of ocular function-preservation rates in maxillary sinus squamous cell carcinomas with orbital invasion.
Sakashita T, Hayashi R, Homma A, Matsuura K, Kato K, Kawabata K, Monden N, Hasegawa Y, Onitsuka T, Fujimoto Y, Iwae S, Okami K, Matsuzuka T, Yoshino K, Fujii M. Sakashita T, et al. Among authors: monden n. Head Neck. 2015 Apr;37(4):537-42. doi: 10.1002/hed.23639. Epub 2014 Apr 9. Head Neck. 2015. PMID: 24715544 Free article.
58 results